RACHEL DUBE: Open Payments
NPI 1962804062 · ROCKWALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$448 in 21 payments from 10 companies in 2025. Trend: 2023 $286 · 2024 $563 · 2025 $448
Food & beverage: $448
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 7 | $155 |
| Novo Nordisk Inc | 4 | $73 |
| PFIZER INC. | 3 | $58 |
| Corcept Therapeutics | 1 | $42 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Dexcom, Inc. | 1 | $23 |
| SHIELD THERAPEUTICS INC | 1 | $19 |
| SANOFI-AVENTIS U.S. LLC | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Amgen Inc. | 1 | $18 |
Products named: FREESTYLE LIBRE 3, Wegovy, Korlym, ELIQUIS, CAPVAXIVE, Dexcom G6 Transmitter, NURTEC ODT, ACCRUFER.
Industry payments across TX — which companies pay providers there.
